Association of kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus: insights from the EMPA-REG OUTCOME trial

被引：0

作者：

Sharma, A. ^{[1
]}

Inzucchi, S. E. ^{[2
]}

Testani, J. ^{[3
]}

Ofstad, A. P. ^{[4
]}

Fitchett, D. ^{[5
]}

Mattheus, M. ^{[6
]}

Verma, S. ^{[7
]}

Zannad, F. ^{[8
]}

Wanner, C. ^{[9
]}

Kraus, B. J. ^{[10
]}

机构：

[1] McGill Univ, Hlth Ctr, Montreal, PQ, Canada

[2] Yale Univ, Sch Med, New Haven, CT USA

[3] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA

[4] Boehringer Ingelheim Norway KS, Asker, Norway

[5] Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON, Canada

[6] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany

[7] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Toronto, ON, Canada

[8] Univ Lorraine, CHRU Nancy, Ctr Invest Clin Plurithemat 1433, INSERM 1116,FCRIN,INI,CRCT, Nancy, France

[9] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany

[10] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：175 / 175

页数：1